September 7th 2024
Collaboration between technology providers and biopharma manufacturers are enabling both evolutionary and novel developments.
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
Gritgen Therapeutics Launches Commercial GMP Facility in China
October 11th 2023The construction of Gritgen’s GMP facility strictly adheres to the global current GMP (CGMP) standards and complies with the regulatory guidelines of authoritative agencies including the National Medical Products Administration (NMPA), FDA, and the European Medicines Agency (EMA).